Best Evaluate Pharma Alternatives for Pharma BD Teams (2026)
Looking for Evaluate Pharma alternatives? Compare leading pharma data platforms for business development teams, including pricing, features, and trade data capabilities.
Ask Questions, Get Answers. No Training Required.
Query pharmaceutical trade data in plain English with our AI copilot. All your data in one place with the simplest user experience in the industry. Try it below with Atorvastatin exports from India.
| Date | HS Code | Product | Generic | Dosage | Qty | Value | Exporter | Dest. |
|---|---|---|---|---|---|---|---|---|
| 2025-07-29 | 29420090 | atorvastatin | - | 2,000 | $270,000 | USA | ||
| 2025-07-29 | 30049079 | atorvastatin | 10mg | 6,082,310 | $139,061 | UK | ||
| 2025-07-29 | 30049079 | atorvastatin | 10mg | 6,018,333 | $137,598 | Germany | ||
| 2025-07-29 | 30049099 | atorvastatin | 10mg | 14,928,000 | $77,917 | Brazil | ||
| 2025-07-29 | 30049099 | atorvastatin | 40mg | 4,374,000 | $77,781 | Canada |
Quick Comparison: PharmaDB vs Evaluate Pharma
| Feature | PharmaDB | Evaluate Pharma | Winner |
|---|---|---|---|
| Global Trade Data | 10M+ shipment records | No trade data | PharmaDB |
| AI Copilot | Yes, natural language queries | Limited | PharmaDB |
| Real-time Export Data | Updated monthly | Not available | PharmaDB |
| Sales Forecasts | No | Consensus forecasts | Evaluate Pharma |
| Pipeline Coverage | Via trade signals | Comprehensive | Evaluate Pharma |
| Supplier Intelligence | 3,000+ exporters | Limited | PharmaDB |
| Pricing Transparency | Per-shipment pricing | Custom quotes only | PharmaDB |
| API Access | Yes | Enterprise only | PharmaDB |
What is Evaluate Pharma?
Evaluate Pharma (now part of Norstella) is a pharmaceutical market intelligence platform providing drug sales forecasts, pipeline analysis, and therapeutic area coverage. Founded in 2005 and headquartered in London, it primarily serves market access, commercial strategy, and investor relations teams with consensus forecasts and analyst reports.
Why Teams Switch from Evaluate Pharma
No Trade Data Coverage
Evaluate Pharma focuses on forecasts and pipeline data but lacks actual trade intelligence. BD teams miss real supplier-buyer relationships and export volumes.
Expensive Enterprise Pricing
Starting at $25,000+/year with no transparent pricing. PharmaDB offers flexible plans starting free, scaling with your needs.
Forecast-Heavy, Action-Light
Great for market sizing but doesn't help identify specific suppliers or track competitor shipments, which is the actionable intel BD teams need.
Complex Analyst Reports
Reports require significant time to digest. PharmaDB's AI copilot gives instant answers to specific questions.
One Platform, All Pharma Data
We're building the unified data layer for pharmaceutical BD teams. Trade data is live today. More datasets coming soon.
Trade Data
LiveGlobal import/export records for APIs, FDFs, and intermediates
MA Holders Registry
SoonMarketing authorization holders across global markets
IP Landscape
SoonPatent expiries, exclusivities, and freedom to operate
Pharma Tenders
SoonGovernment and institutional procurement opportunities
Drug Shortages
SoonReal-time shortage notices and supply disruptions
Companies & People
SoonPharma company profiles and key decision makers
All datasets accessible through one AI copilot, one subscription.
Why BD Teams Choose PharmaDB Over Evaluate Pharma
While Evaluate Pharma excels at market forecasts and pipeline analysis, it lacks the ground-level trade intelligence that BD teams need for day-to-day operations.
Trade Data vs. Forecasts
See the difference between what each platform delivers.
- What the Gabapentin market might be worth in 5 years.
- Which companies exported Gabapentin last month
- What prices they charged per kg
- Which markets they shipped to
- How their volumes compare to competitors
This is the difference between strategic planning and tactical execution.
Real-World Use Cases
Supplier Sourcing
Find qualified API manufacturers with proven export track records to regulated markets.
Competitive Intelligence
Track what your competitors are shipping, where, and at what price points.
Market Entry
Understand import patterns before entering new geographies.
Due Diligence
Verify supplier claims with actual shipment data.
When to Use Each Platform
- Supplier identification and qualification
- Competitor export tracking
- Real-time trade intelligence
- Price benchmarking from actual shipments
- Long-term sales forecasts
- Pipeline analysis and drug profiles
- Consensus analyst estimates
- Therapeutic area deep-dives
Many enterprise teams use both platforms together: Evaluate for strategic planning and PharmaDB for tactical execution.
Frequently Asked Questions
Is PharmaDB better than Evaluate Pharma?
PharmaDB and Evaluate Pharma serve different needs. PharmaDB excels at trade data, supplier discovery, and real-time export intelligence, which is essential for BD teams sourcing APIs or tracking competitor shipments. Evaluate Pharma is better for sales forecasts and pipeline analysis. Many teams use both for complete coverage.
What's cheaper than Evaluate Pharma?
PharmaDB offers a free tier and transparent pricing starting significantly lower than Evaluate Pharma's $25,000+ annual contracts. You get trade data coverage that Evaluate Pharma doesn't offer at any price point.
Can I get pharma trade data from Evaluate Pharma?
No, Evaluate Pharma does not provide trade or shipment data. Their focus is on sales forecasts, pipeline analysis, and consensus estimates. For trade intelligence including actual export volumes, supplier relationships, and shipment-level pricing, you need a specialized platform like PharmaDB.
Who owns Evaluate Pharma?
Evaluate Pharma is part of Norstella, formed in 2022 through the merger of several healthcare data companies including Evaluate, Citeline, and others. The combined entity serves pharmaceutical companies with various data and analytics solutions.
What data does Evaluate Pharma include?
Evaluate Pharma provides drug sales forecasts, pipeline analysis, deal data, therapeutic area reports, and consensus estimates from financial analysts. It does not include trade data, supplier intelligence, or export/import records that BD teams need for sourcing and supplier evaluation.
Ready to try PharmaDB?
See why BD teams are switching from Evaluate Pharma to PharmaDB for trade intelligence.
Start for free